These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17138916)

  • 21. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
    Ganju D; Ramesh S; Saggurti N
    Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demographic characteristics, treatment history, drug risk behaviors, and condom use attitudes for U.S. and Russian injection drug users: the need for targeted sexual risk behavior interventions.
    Ksobiech K; Somlai AM; Kelly JA; Gore-Felton C; Benotsch E; McAuliffe T; Hackl K; Ostrovski D; Kozlov AP
    AIDS Behav; 2005 Mar; 9(1):111-20. PubMed ID: 15812618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
    Lurie P; Jones TS; Foley J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990.
    Hahn JA; Vranizan KM; Moss AR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):157-64. PubMed ID: 9241116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
    Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
    Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
    Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.
    Judd A; Rhodes T; Johnston LG; Platt L; Andjelkovic V; Simić D; Mugosa B; Simić M; Zerjav S; Parry RP; Parry JV
    BMC Infect Dis; 2009 Feb; 9():14. PubMed ID: 19203380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.
    Bluthenthal RN; Kral AH; Erringer EA; Edlin BR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):505-11. PubMed ID: 9715848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to hepatitis B virus vaccination at syringe exchange sites.
    Altice FL; Bruce RD; Walton MR; Buitrago MI
    J Urban Health; 2005 Mar; 82(1):151-61. PubMed ID: 15746385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
    Des Jarlais DC; Perlis T; Arasteh K; Hagan H; Milliken J; Braine N; Yancovitz S; Mildvan D; Perlman DC; Maslow C; Friedman SR
    J Acquir Immune Defic Syndr; 2004 Feb; 35(2):158-66. PubMed ID: 14722449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities.
    Murrill CS; Weeks H; Castrucci BC; Weinstock HS; Bell BP; Spruill C; Gwinn M
    Am J Public Health; 2002 Mar; 92(3):385-7. PubMed ID: 11867316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City.
    Crawford ND; Amesty S; Rivera AV; Harripersaud K; Turner A; Fuller CM
    Am J Public Health; 2013 Sep; 103(9):1579-82. PubMed ID: 23865644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.
    Vorobjov S; Uusküla A; Abel-Ollo K; Talu A; Jarlais DD
    J Urban Health; 2009 Nov; 86(6):918-28. PubMed ID: 19921542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange.
    Heimer R
    Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S65-73. PubMed ID: 18207726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.